Centre Says 120 Adverse Events Reported After Nearly 56 Lakh HPV Vaccine Doses Administered

Centre Says 120 Adverse Events Reported After Nearly 56 Lakh HPV Vaccine Doses Administered

The Centre has informed the Delhi High Court that 120 cases of adverse events following immunisation (AEFI) have been reported after nearly 56 lakh doses of HPV vaccine were administered in India. The court has refused to stay the HPV vaccination drive, which is currently underway across the country. The Centre has assured the court that the vaccine is safe and effective, and that the reported adverse events are rare and minor.